Dessoude Loïse, Lemaire Raphaëlle, Andres Romain, Leleu Thomas, Leclercq Alexandre G, Desmonts Alexis, Corroller Typhaine, Orou-Guidou Amirath Fara, Laduree Luca, Henaff Loic Le, Lacroix Joëlle, Lechervy Alexis, Stefan Dinu, Corroyer-Dulmont Aurélien
Radiotherapy Department, Centre François Baclesse, Caen 14000, France.
Medical Physics Department, Centre François Baclesse, Caen 14000, France.
Neuroimage. 2025 Feb 1;306:121002. doi: 10.1016/j.neuroimage.2025.121002. Epub 2025 Jan 10.
The RANO-BM criteria, which employ a one-dimensional measurement of the largest diameter, are imperfect due to the fact that the lesion volume is neither isotropic nor homogeneous. Furthermore, this approach is inherently time-consuming. Consequently, in clinical practice, monitoring patients in clinical trials in compliance with the RANO-BM criteria is rarely achieved. The objective of this study was to develop and validate an AI solution capable of delineating brain metastases (BM) on MRI to easily obtain, using an in-house solution, RANO-BM criteria as well as BM volume in a routine clinical setting.
MATERIALS (PATIENTS) AND METHODS: A total of 27,456 post-Gadolinium-T1 MRI from 132 patients with BM were employed in this study. A deep learning (DL) model was constructed using the PyTorch and PyTorch Lightning frameworks, and the UNETR transfer learning method was employed to segment BM from MRI.
A visual analysis of the AI model results demonstrates confident delineation of the BM lesions. The model shows 100 % accuracy in predicting RANO-BM criteria in comparison to that of an expert medical doctor. There was a high degree of overlap between the AI and the doctor's segmentation, with a mean DICE score of 0.77. The diameter and volume of the BM lesions were found to be concordant between the AI and the reference segmentation. The user interface developed in this study can readily provide RANO-BM criteria following AI BM segmentation.
The in-house deep learning solution is accessible to everyone without expertise in AI and offers effective BM segmentation and substantial time savings.
RANO-BM标准采用最大直径的一维测量方法,由于病变体积既非各向同性也非均匀性,所以并不完善。此外,这种方法本身就很耗时。因此,在临床实践中,很少能按照RANO-BM标准对临床试验中的患者进行监测。本研究的目的是开发并验证一种人工智能解决方案,该方案能够在MRI上勾勒出脑转移瘤(BM),以便在常规临床环境中使用内部解决方案轻松获取RANO-BM标准以及BM体积。
材料(患者)与方法:本研究使用了132例患有BM的患者的27456张钆增强T1加权MRI图像。使用PyTorch和PyTorch Lightning框架构建了深度学习(DL)模型,并采用UNETR迁移学习方法从MRI中分割出BM。
对人工智能模型结果的可视化分析表明,其能够可靠地勾勒出BM病变。与医学专家相比,该模型在预测RANO-BM标准方面的准确率为100%。人工智能分割结果与医生的分割结果高度重叠,平均DICE评分为0.77。发现BM病变的直径和体积在人工智能分割结果与参考分割结果之间具有一致性。本研究开发的用户界面能够在人工智能对BM进行分割后轻松提供RANO-BM标准。
这种内部深度学习解决方案无需人工智能专业知识,人人都可使用,能有效分割BM,大幅节省时间。